Abstract
The activity of cell-mediated defense systems is stimulated by consecutive formation of interleukin-1β (IL-1β), interleukin-2 (IL-2) and interferon γ (IFNγ). The system is inhibited by interleukin-4 (IL-4) and also by prostaglandin E2 (PGE2) and histamine, which are released when the immune system is activated. The inhibition is strong in cancer patients, because PGE2 is formed in many cancer cells and its formation is stimulated by IL-1β. The release of histamine is also stimulated by IL-1β. Tus PGE2 and histamine are feedback inhibitors of cell-mediated immunity. This inhibition can be abolished by inhibitors of the cyclo-oxygenase (e. g. indomethacin) and H-2 receptor antagonists (e. g. cimetidine). This may offer a new option to stimulate the immune system to kill cancer cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Akama H, Ickikawa Y, Matsushit Y, Shinozawa T, Homma M (1990) Mononuclear cells enhance prostaglandin E2 production of polymorphonuclear leukocytes via tumor necrosis factor α. Biochem Biophys Res Commun 168: 857
Allen JI, Syropoulus HJ, Grant B (1987) Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia. J Lab Clin Med 109: 396
Arend WP, Gordon DF, Wood WM, Janson RW, Joslin FG, Jameel S (1989) IL-1β production in cultured human monocytes is regulated at multiple levels. J Immunol 143: 118
Armitage JO, Sidner RD (1979) Antitumor effect of cimetidine? Lancet 1: 882
Bray RA, Brahmi Z (1986) Role of lipoxygenation in human natural killer cell activation. J Immunol 136: 1783
Brockmeyer NH, Kreuzfelder E, Chalabi N, Scheiermann N, Keinecke HO, Goos M, Ohnhaus EE (1989) The immunomodulatory potency of cimetidine in healthy volunteers. Int J Clin Pharmacol Ther Toxicol 27: 458
di Giovine F, Duff GW (1990) Interleukin 1: the first interleukin. Immunol Today 11: 13
Dohlsten M (1988) Suppressive effects of histamine on T cell activation. Academic dissertation, University of Lund, Lund
Dohlsten M, Sjögren HO, Carlsson R (1987) Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-γ production. Cell Immunol 109: 65
Dohlsten M, Hedlund G, Fischer H, Sjögren HO, Carlsson R (1989) Proliferation of human CD4+45R+ and CD+45R− T helper cells is promoted by both IL-2 and IL-4 while interferon-gamma production is restricted to IL-2 activated CD4+45R− T cells. Immunol Lett 20: 29
Donnelly RP, Fenton MJ, Kaufmann JD, Gerrard TL (1991) IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4. J Immunol 146: 3431
Essner R, Rhoades K, McBride WH, Morton DL, Economou JS (1989) IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 142: 3857
Falus A, Meretey K (1992) Histamine: an early messenger in inflammatory and immune reactions. Immunol Today 13: 154
Fischer H, Hedlund G, Kalland T, Sjögren HO, Dohlsten M (1990) Independent regulation of IFN-γ and tumor necrosis factor by IL-1 in human T helper cells. J Immunol 145: 3767
Garcia-Penarrubia P, Bankhurst AD, Koster FT (1989) Prostaglandins from human T suppressor/cytotoxic cells modulate natural killer antibacterial activity. J Exp Med 170: 601
Goodwin JS (1985) Immunologic effects of nonsteroidal anti-inflammatory drugs. Med Clin North Am 69: 793
Goodwin JS, Kaszubowski PA, Williams RC Jr (1979) Cyclic adenosine monophosphate response to prostaglandin E2 in subpopulations of human lymphocytes. J Exp Med 150: 1260
Goto T, Herberman RB, Maluish A, Strong DM (1983) Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. J Immunol 130: 1350
Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA (1989) Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 86: 3803
Hart PH, Whitty GA, Piccoli DS, Hamilton JA (1989) Control by IFN-γ and PGE2 of TNFα and IL-1 production by human monocytes. Immunology 66: 376
Hellstrand K, Hermodsson S (1987) Differential effects of histamine receptor antagonists on human natural killer cell activity. Int Arch Allergy Appl Immunol 84: 247
Hellstrand K, Hermodsson S (1990) A cell-to-cell mediated interaction involving monocytes and non-T/CD 16+ natural killer (NK) cells is required for histamine H2-receptor-mediated NK-cell activation. Scand J Immunol 31: 631
Hellstrand K, Asea A, Hermodsson S (1990) Role of histamine in natural killer cell-mediated resistance against tumor cells. J Immunol 145: 4365
Hotermans G, Bury T, Radermecker MF (1991) Effect of histamine on tumor necrosis factor production by human monocytes. Int J Allergy Appl Immunol 95: 278
Ijzermans JNM, Marquet RL (1989) Interferon-gamma: a review. Immunobiology 179: 456
Kärre K, Hansson M, Kiessling R (1991) Multiple interactions at the natural killer workshop. Immunol Today 12: 343
Kaplan AP, Reddigari S, Baeza M, Kuna P (1991) Histamine releasing factors and cytokine-dependent activation of basophils and mast cells. Adv Immunol 50: 237
Khan MM, Sansoni P, Engleman EG, Melmon KL (1985) Pharmacologic effects of autacoids on subsets of T cells. J Clin Invest 75: 1578
Koren HS, Anderson SJ, Fischer DG, Copeland CS, Jensen PJ (1981) Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins. J Immunol 127: 2007
Krause DS, Deutsch C (1991) Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. J Immunol 146: 2285
Kuna P, Reddigari SR, Kornfeld D, Kaplan AP (1991) IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connetive tissue activating peptide III, and IL-3. J Immunol 147: 1920
Kunkel IL, Spengler M, May MA, Spengler R, Larrick J, Remick D (1988) Prostaglandin E2 regulates macrophage-derived tumor necrosis factor. J Biol Chem 263: 5380
Last-Barney K, Homon CA, Faanes RB, Merluzzi VJ (1988) Synergistic and overlapping activities of tumor necrosis factor-α and IL-1. J Immunol 141: 527
Mary D, Aussel C, Ferrua B, Fehlmann M (1987) Regulation of interleukin 2 synthesis by cAMP in human T cells. J Immunol 139: 1179
Merluzzi VJ, Faanes RB, Czajkowski M, Last-Barney K, Harrison PC, Kahn J, Rothlein R (1987) Membrane-associated interleukin 1 activity on human U937 tumor cells: stimulation of PGE2 production by human chondrosarcoma cells. J Immunol 139: 166
Mertens WC, Bramwell VHC, Gwadry-Sridhar F, Romano W, Banerjee D, Lala PK (1992) Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2. Lancet 340: 397
Meyer JD, Yurt RW, Duhaney R, Hesse DG, Tracey KJ, Fong Y, Verma M, Shires GT, Dineen P, Lowry SF, Davis JM (1988) Tumor necrosis factor—enhanced leukotriene B4 generation and chemotaxis in human neutrophils. Arch Surg 123: 1454
Mizel SB (1989) The interleukins. FASEB J 3: 2379
Moxey-Mims MM, Simms HH, Frank MM, Lin EY, Gaither TA (1991) The effects of IL-1, IL-2, and tumor-necrosis factor on polymorphonuclear leukocyte Fcy receptor-mediated phagocytosis. J Immunol 147: 1823
Newton RC (1985) Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity. Immunology 56: 441
Pene J, Rousset F, Briere F, Chretien I, Paliard X, Banchereau J, Spits H, De Vries JE (1988) IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-γ. J Immunol 141: 1218
Phipps RP, Stein SH, Roper RL (1991) A new view of prostaglandin E regulation of the immune response. Immunol Today 12: 349
Ramstedt U, Ng J, Wigzell H, Serhan CN, Samuelsson B (1985) Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects on intracellular cAMP and target cell binding. J Immunol 135: 3434
Rappaport RS, Dodge GR (1982) Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 155: 943
Rincon M, Tugores A, Lopez-Rivas A, Silva A, Alonso M, De Landazuri MO Lopez-Botet M (1988) Prostaglandin E2 and the increase of intracellular cAMP inhibits the expression of interleukin-2 receptors in human T cells. Eur J Immunol 18: 1791
Rola-Pleszczynski M, Gagnon L, Sirois P (1983) Leukotriene B4 augments human natural cytotoxic cell activity. Biochem Biophys Res Commun 113: 531
Samuelsson B (1983) Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220: 568
Schröder J-M (1989) The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J Exp Med 170: 847
Smith KA (1990) Interleukin-2. Sci Am 262: 50
Smith TJ, Kaplowitz LG (1991) Pilot study of cimetidine in the treatment of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. JNCI 83: 139
Standiford TJ, Strieter RM, Chensue SW, Westwick J, Kasahara K, Kunkel SL (1990) IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol 145: 1435
Strieter RM, Chensue SW, Standiford TJ, Basha MA, Showell HJ, Kunkel SL (1990) Disparate gene expression of chemotactic cytokines by human mononuclear phagocytes. Biochem Biophys Res Commun 166: 886
Strieter RM, Remick DG, Ham JM, Colletti LM, Lynch JP, Kunkel SL (1990) Tumor necrosis factor-alpha gene expression in human blood. J Leukoc Biol 47: 366
Subramanian N, Bray MA (1987) Interleukin 1 releases histamine from human basophils and mast cells in vitro. J Immunol 138: 271
Topley N, Floege J, Wessel K, Hass R, Radeke HH, Kaever V, Resch K (1989) Prostaglandin E2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-α. J Immunol 143: 1989
Uotila P, Vapaatalo H (1984) Synthesis, pathways and biological implications of eicosanoids. Ann Clin Res 16: 226
Walker C, Kristensen F, Bettens F, de Weck AL (1983) Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. J Immunol 130: 1770
Yang J, Zucker-Franklin D (1984) Modulation of natural killer (NK) cells by autologous neutrophils and monocytes. Cell Immunol 86: 171
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uotila, P. Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy. Cancer Immunol Immunother 37, 251–254 (1993). https://doi.org/10.1007/BF01518519
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01518519